Boceprevir

Contraindicated

Boceprevir Colchicine Colcrys Explained Increased colchicine exposure and an increased risk of fatal toxicity Details Boceprevir Simvastatin Flolipid Explained Increased simvastatin concentrations and risk of myopathy and rhabdomyolysis Details Boceprevir Alfuzosin UroXatral Increased alfuzosin exposure Details Boceprevir Dihydroergotamine Injection DHE-45® Injection Increased dihydroergotamine exposure and an increased risk of dihydroergotamine-related adverse effects Details Boceprevir Dihydroergotamine Nasal Spray Migranal Increased dihydroergotamine exposure and an increased risk of dihydroergotamine-related adverse effects Details Boceprevir Doxazosin Cardura Increased doxazosin exposure Details Boceprevir Finerenone Kerendia Increased finerenone exposure and an increased risk of finerenone-related adverse effects Details Boceprevir Ivabradine Corlanor Increased ivabradine exposure and an increased risk of ivabradine-related adverse effects [like bradycardia and conduction disturb... Details Boceprevir Lovastatin Altocor® Increased lovastatin exposure and an increased risk of lovastatin-related adverse effects, such as risk of myopathy and rhabdomyol... Details Boceprevir Lurasidone Latuda Increased lurasidone exposure Details Boceprevir Methylergonovine Methergine An increased risk of acute ergot toxicity (peripheral vasospasm, ischemia of the extremities) Details Boceprevir Midazolam Nasal Spray Nayzilam Increased midazolam concentrations Details Boceprevir Midazolam Injection Nayzilam Increased midazolam concentrations Details Boceprevir Naloxegol Movantik Increased naloxegol exposure and an increased risk of naloxegol-related adverse effects Details Boceprevir Nimodipine Nimotop Increased plasma concentrations of nimodipine Details

Major

Boceprevir Acetaminophen And Codeine Capital® & Codeine Explained Increased codeine and morphine exposure Details Boceprevir Abametapir Explained Increased exposure of CYP3A4 substrate Details Boceprevir Buprenorphine Belbuca Explained Increased buprenorphine exposure and an increased risk of buprenorphine-related adverse events Details Boceprevir Relugolix Orgovyx Explained Increased relugolix exposure Details Boceprevir Acalabrutinib Calquence Increased acalabrutinib exposure Details Boceprevir Ado-Trastuzumab Emtansine Injection KADCYLA Increased exposure of cytotoxic component DM1 (maytansine derivative) and risk of toxicity Details Boceprevir Apixaban Eliquis Explained Increased apixaban exposure and an increased risk of bleeding Details Boceprevir Aripiprazole Injection Abilify Increased ARIPiprazole exposure Details Boceprevir Asciminib Scemblix Increased asciminib exposure and an increased risk of asciminib-related adverse effects Details Boceprevir Atogepant Qulipta Altered atogepant exposure Details Boceprevir Avapritinib Ayvakit Increased avapritinib exposure and increased incidence and severity of adverse reactions Details Boceprevir Atorvastatin Atorvaliq Increased atorvastatin exposure Details Boceprevir Cariprazine Vraylar Explained Increased exposure to cariprazine and its active metabolite, didesmethylcariprazine Details Boceprevir Amlodipine Amvaz® Increased amLODIPine exposure, an increased risk of hypotension and edema and reduced amLODIPine exposure Details Boceprevir Avanafil Stendra Decreased avanafil clearance and increased avanafil plasma concentration Details Boceprevir Axitinib Inlyta Increased axitinib plasma concentrations Details Boceprevir Beclomethasone Nasal Spray Beconase Increased beclomethasone exposure and an increased risk of beclomethasone-related adverse reactions Details Boceprevir Beclomethasone Oral Inhalation Beclovent® Increased beclomethasone exposure and an increased risk of beclomethasone-related adverse reactions Details Boceprevir Bedaquiline Sirturo Increased bedaquiline exposure Details Boceprevir Bosutinib Bosulif Increased bosutinib exposure Details Boceprevir Brentuximab Vedotin Injection Adcetris Increased exposure to active entity of brentuximab vedotin Details Boceprevir Brexpiprazole Rexulti Increased brexpiprazole exposure Details Boceprevir Brigatinib Alunbrig Increased brigatinib exposure Details Boceprevir Budesonide Entocort Increased budesonide exposure and significantly reduced serum cortisol concentrations Details Boceprevir Budesonide Nasal Spray Rhinocort Increased budesonide exposure and significantly reduced serum cortisol concentrations Details